Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus Infection
Antiretroviral therapy has prolonged the lives of people living with human immunodeficiency virus type 1 (HIV-1), transforming the disease into one that can be controlled with lifelong therapy. The search for an HIV-1 vaccine has plagued researchers for more than three decades with little to no succ...
Main Authors: | Alexander G. Allen, Cheng-Han Chung, Andrew Atkins, Will Dampier, Kamel Khalili, Michael R. Nonnemacher, Brian Wigdahl |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-12-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmicb.2018.02940/full |
Similar Items
-
Designing Safer CRISPR/Cas9 Therapeutics for HIV: Defining Factors That Regulate and Technologies Used to Detect Off-Target Editing
by: Neil T. Sullivan, et al.
Published: (2020-08-01) -
Computational Design of gRNAs Targeting Genetic Variants Across HIV-1 Subtypes for CRISPR-Mediated Antiviral Therapy
by: Cheng-Han Chung, et al.
Published: (2021-03-01) -
Off-Target Analysis in Gene Editing and Applications for Clinical Translation of CRISPR/Cas9 in HIV-1 Therapy
by: Andrew Atkins, et al.
Published: (2021-08-01) -
Safe CRISPR-Cas9 Inhibition of HIV-1 with High Specificity and Broad-Spectrum Activity by Targeting LTR NF-κB Binding Sites
by: Cheng-Han Chung, et al.
Published: (2020-09-01) -
HIV-1 Tat Length: Comparative and Functional Considerations
by: Anthony R. Mele, et al.
Published: (2020-03-01)